1420 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
2 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
5 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
6 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
7 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
8 Recruiting Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Condition: External Genital Warts
Interventions: Drug: LFX453;   Drug: Aldara®
9 Not yet recruiting First Event of Infection by HIV-1 of Uterine Vaginal Tissue
Condition: HIV Infection of the Uterine Vaginal Tissues
Intervention:
10 Active, not recruiting Randomized Controlled Trial of Shang Ring Children Circumcision: Comparison Between Flip and No Flip Technique
Condition: Human Immunodeficiency Virus
Interventions: Device: No flip technique of Shang Ring circumcision;   Device: Flip technique of Shang Ring circumcision
11 Not yet recruiting Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/GS-5816
12 Active, not recruiting Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection
Condition: Treatment of Hepatitis C
Intervention: Drug: Ledipasvir/Sofosbuvir FDC
13 Not yet recruiting Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Subjects do not receive study medication in this study 202094
14 Not yet recruiting Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir tablet 30 mg once daily for 28 days.;   Drug: Cabotegravir injection 400 mg/2mL (2 x 400 mg split injection) IM given once on Day 1.
15 Recruiting Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: Vorinostat;   Drug: Hydroxychloroquine;   Drug: Maraviroc;   Drug: Tenofovir;   Drug: Emtricitabine;   Drug: Efavirenz;   Drug: Darunavir
16 Not yet recruiting The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
Condition: HIV Infection
Interventions: Drug: Raltegravir 1200 mg;   Drug: TUMS;   Drug: MAALOX
17 Not yet recruiting VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
Condition: HIV
Intervention: Biological: VRC-HIVMAB060-00-AB (VRC01)
18 Not yet recruiting Acute Partner and Social Contact Referral: iKnow
Conditions: Acute HIV Infection;   HIV Seropositive;   Sexually Transmitted Infections
Intervention: Other: Notification cards
19 Recruiting Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: Trauma-Informed Cognitive Behavioral Therapy enhanced (TI-CBTe)
20 Not yet recruiting Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa
Condition: Human Immunodeficiency Virus
Interventions: Drug: cabotegravir;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years